TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15471934

Group type: EXPERIMENTAL
Intervention: PGD‐AS (Preimplantation Genetic Diagnosis for Aneuploidy Screening)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group (without PGD‐AS)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: PGD‐AS
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 400
Study: 11748505

Group type: EXPERIMENTAL
Intervention: Aerobic training (P1 and P4)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Strength training (P2 and P5)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Combination of aerobic and strength training (P4 and P6)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (P1 - P3 without supplemental oxygen)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (P4 - P6 with supplemental oxygen)
Number of subjects: 69
Study: 9250896

Group type: EXPERIMENTAL
Intervention: Immunochemical fecal occult blood test
Number of subjects: 341
Study: 7995681

Group type: EXPERIMENTAL
Intervention: GGGS treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3518342

Group type: EXPERIMENTAL
Intervention: Laparotomy with splenectomy
Number of subjects: 69

Group type: COMPARATOR
Intervention: Total nodal irradiation (excluding the splenic and hepatic areas)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Splenectomized patients with splenic tumour involvement
Number of subjects: 69
Study: 28961020

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/vilanterol (FF/VI) 100/25 µg
Number of subjects: 1504

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate/salmeterol (FP/SAL) 250/50 µg
Number of subjects: 1504

Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) 250 µg
Number of subjects: 1504
Study: 27777438

Group type: EXPERIMENTAL
Intervention: Indirect bonding technique
Number of subjects: 100

Group type: COMPARATOR
Intervention: Direct bonding technique
Number of subjects: 100
Study: 24983951

Group type: EXPERIMENTAL
Intervention: Visual art production
Number of subjects: 28

Group type: COMPARATOR
Intervention: Cognitive art evaluation
Number of subjects: 28
Study: 21767927

Group type: EXPERIMENTAL
Intervention: Chronic Disease Self-Management Programme (CDSMP)
Number of subjects: 629

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 629
Study: 20133502

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Usual care plus an information program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Usual care plus a decision analysis program
Number of subjects: 0
Study: 17764779

Group type: EXPERIMENTAL
Intervention: Docetaxel 35mg/m(2) IV on days 1 and 8 plus daily oral UFUR 150mg/m(2) of every 3 weeks (arm DU)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Docetaxel 40mg/m(2) IV on days 1 and 8 of every 3 weeks (arm D)
Number of subjects: 48
Study: 15673894

Group type: EXPERIMENTAL
Intervention: 2-chloroprocaine with clonidine (15 microg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: 2-chloroprocaine (30 mg)
Number of subjects: 8
Study: 11755289

Group type: EXPERIMENTAL
Intervention: High-dose enalapril (40 mg/day)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Low-dose enalapril (5 mg/day)
Number of subjects: 75
Study: 10347965

Group type: EXPERIMENTAL
Intervention: Upper Limb Training (UL)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Lower Limb Training (LL)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both groups (LL and UL)
Number of subjects: 28
Study: 7647181

Group type: EXPERIMENTAL
Intervention: Multifaceted approach including performance-based measures, cognitive tests, and physiological assessments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physiological assessments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Performance-based measures
Number of subjects: 0
Study: 2788406

Group type: EXPERIMENTAL
Intervention: Ostoprin (4.0 g per day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ecotrin (3.9 g per day)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both Ostoprin and Ecotrin
Number of subjects: 40
Study: 15901

Group type: EXPERIMENTAL
Intervention: Ovral
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Norinyl 1/50
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Nortestrin 1
Number of subjects: 480
Study: 30666100

Group type: EXPERIMENTAL
Intervention: IND/GLY 110/50 µg once daily
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 28154349

Group type: EXPERIMENTAL
Intervention: 2.5 g/d of ALA‐DAG
Number of subjects: 16

Group type: COMPARATOR
Intervention: TAG (control)
Number of subjects: 16
Study: 25932833

Group type: EXPERIMENTAL
Intervention: Mnemonic counseling
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard counseling
Number of subjects: 90
Study: 24035165

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 1150

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 1150
Study: 21814588

Group type: EXPERIMENTAL
Intervention: Ivermectin (single dose, 200 µg/kg)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Thiabendazole (two daily doses of 25 mg/kg for two days)
Number of subjects: 198
Study: 19405831

Group type: EXPERIMENTAL
Intervention: Acellular dermal matrix (ADM)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Polytetrafluoroethylene (PTFE) membrane
Number of subjects: 20
Study: 16896932

Group type: EXPERIMENTAL
Intervention: Combined diet and exercise programme (47 intervention)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (50 control subjects)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Lifestyle programme
Number of subjects: 97
Study: 15303645

Group type: EXPERIMENTAL
Intervention: Inhaled plus oral corticosteroids (O group)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Corticosteroid treatment in unstable asthmatics
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Corticosteroid treatment intensity
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Corticosteroid treatment
Number of subjects: 101
Study: 10641044

Group type: EXPERIMENTAL
Intervention: Taiga Wurzel (25 drops three times daily for 30 days)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Echinacea (40 drops three times daily for 30 days)
Number of subjects: 50
Study: 8694312

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.6 mg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Vecuronium 0.1 mg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Atracurium 0.5 mg/kg
Number of subjects: 60
Study: 1426372

Group type: EXPERIMENTAL
Intervention: Gonadotropin-releasing hormone agonists (GnRH-a)
Number of subjects: 1636

Group type: COMPARATOR
Intervention: Short flare-up GnRH-a protocols
Number of subjects: 1636
Study: 4082084

Group type: EXPERIMENTAL
Intervention: Evening primrose oil (EPO) 12 capsules/day for 8 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo for 2 weeks followed by placebo for 8 weeks
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Evening primrose oil (EPO)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 31615581

Group type: EXPERIMENTAL
Intervention: RecoveryMANTRA (experimental group)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU) (control group)
Number of subjects: 187
Study: 29846607

Group type: EXPERIMENTAL
Intervention: Once-daily modified-release hydrocortisone
Number of subjects: 89

Group type: COMPARATOR
Intervention: Multiple daily glucocorticoid doses
Number of subjects: 89
Study: 28199748

Group type: EXPERIMENTAL
Intervention: DL‐PDT with topical 10% methylene blue gel
Number of subjects: 40

Group type: COMPARATOR
Intervention: DL‐PDT with hematoxylin (placebo)
Number of subjects: 40
Study: 26348226

Group type: EXPERIMENTAL
Intervention: Exercise in nature (outdoor)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Indoor exercise
Number of subjects: 19
Study: 24002279

Group type: EXPERIMENTAL
Intervention: 2-4-6 schedule
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: 3-5 schedule
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: 4 different PCV13 immunization schedules
Number of subjects: 400
Study: 21560266

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (1 mg, pressurized metered dose inhaler)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 19055209

Group type: EXPERIMENTAL
Intervention: Acupuncture (up to 15 sessions over 3 months)
Number of subjects: 487

Group type: COMPARATOR
Intervention: Control (routine care alone)
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 487

Group type: COMPARATOR
Intervention: Control
Number of subjects: 487
Study: 17015555

Group type: EXPERIMENTAL
Intervention: Personalized parent voice smoke alarm
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional residential tone smoke alarm
Number of subjects: 24
Study: 12663573

Group type: EXPERIMENTAL
Intervention: Nurse-care management system (n = 84)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Usual medical care (n = 85)
Number of subjects: 169
Study: 10704275

Group type: EXPERIMENTAL
Intervention: Remote organ ischaemia via tourniquet (3 min ischaemia, 2 min reperfusion)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (no preconditioning)
Number of subjects: 8
Study: 8865530

Group type: EXPERIMENTAL
Intervention: Dalteparin (200 IU anti-factor Xa/kg, subcutaneously once daily)
Number of subjects: 253

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH, continuous intravenous infusion)
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Dalteparin
Number of subjects: 253

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Dalteparin and UFH
Number of subjects: 253
Study: 1298487

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine HCl with 1:200,000 epinephrine
Number of subjects: 24

Group type: COMPARATOR
Intervention: 2% lidocaine HCl with 1:100,000 epinephrine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Postoperative discomfort
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Overall success rate
Number of subjects: 24
Study: 6377843

Group type: EXPERIMENTAL
Intervention: Anxiety Reduction
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control
Number of subjects: 53
Study: 2423343

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: COMPARATOR
Intervention: Verapamil 3 X 80 mg
Number of subjects: 10
Study: 29299613

Group type: EXPERIMENTAL
Intervention: Critical Time Intervention (CTI)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 136
Study: 26451007

Group type: EXPERIMENTAL
Intervention: Core stability exercises for 15 min/day in addition to conventional therapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 80
Study: 25896352

Group type: EXPERIMENTAL
Intervention: Liraglutide treatment for 10 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 24
Study: 23720785

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stretching and deep breathing exercise (MBX)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 29
Study: 19797974

Group type: COMPARATOR
Intervention: Coronary Artery Bypass Grafting (CABG)
Number of subjects: 472

Group type: COMPARATOR
Intervention: Percutaneous Coronary Intervention (PCI)
Number of subjects: 472
Study: 19055813

Group type: EXPERIMENTAL
Intervention: FACT (Flexible Assertive Community Treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment (control)
Number of subjects: 0
Study: 16634535

Group type: EXPERIMENTAL
Intervention: n-3 fatty acids
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 161
Study: 12789171

Group type: EXPERIMENTAL
Intervention: Infliximab 5 mg/kg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Infliximab 10 mg/kg
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 11199369

Group type: EXPERIMENTAL
Intervention: Recombinant IFN-alpha2a
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: IFN-alpha2b
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Lymphoblastoid IFN-alpha1
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Overall (all treatments)
Number of subjects: 95
Study: 8617708

Group type: EXPERIMENTAL
Intervention: Sertraline (200 mg/day for 10 days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 30
Study: 1614045

Group type: EXPERIMENTAL
Intervention: Dilevalol 200 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Enalapril 5 mg
Number of subjects: 8
Study: 6584445

Group type: EXPERIMENTAL
Intervention: 0.5% metronidazole solution in dialysis tubing
Number of subjects: 10

Group type: COMPARATOR
Intervention: 0.2% chlorhexidine subgingival irrigation
Number of subjects: 10
Study: 31757218

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 0
Study: 27821548

Group type: EXPERIMENTAL
Intervention: Positive Action (PA) program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition activities
Number of subjects: 0
Study: 25650040

Group type: EXPERIMENTAL
Intervention: Cyanoacrylate embolization (CAE) with the VenaSeal Sapheon Closure System (n = 108)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Radiofrequency ablation (RFA) with the ClosureFast system (n = 114)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Cyanoacrylate embolization (CAE)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 222
Study: 23643716

Group type: EXPERIMENTAL
Intervention: Walking program (8-week physiotherapy-delivered walking program)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Supervised exercise class (8-week group supervised exercise class, 1 class/week)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Usual physiotherapy (1-to-1 advice, manual therapy, and exercise)
Number of subjects: 60
Study: 20336348

Group type: EXPERIMENTAL
Intervention: Cilengitide 500 mg IV twice weekly
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Cilengitide 2000 mg IV twice weekly
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 44
Study: 19246849

Group type: EXPERIMENTAL
Intervention: Telmisartan 40 mg and HCTZ 12.5 mg once daily
Number of subjects: 21

Group type: COMPARATOR
Intervention: Losartan 50 mg and HCTZ 12.5 mg once daily
Number of subjects: 21
Study: 16725141

Group type: EXPERIMENTAL
Intervention: Granulosa cell‐conditioned medium from smokers
Number of subjects: 100

Group type: COMPARATOR
Intervention: Granulosa cell‐conditioned medium from nonsmokers
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Follicular fluid from smokers
Number of subjects: 100

Group type: COMPARATOR
Intervention: Follicular fluid from nonsmokers
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: HUVECs cultured with follicular fluid from smokers
Number of subjects: 100

Group type: COMPARATOR
Intervention: HUVECs cultured with follicular fluid from nonsmokers
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cotinine concentration in smoking women
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cotinine concentration in nonsmoking women
Number of subjects: 100
Study: 15019670

Group type: EXPERIMENTAL
Intervention: On-pump CABG with cardiopulmonary bypass and cardioplegic arrest
Number of subjects: 114

Group type: COMPARATOR
Intervention: Off-pump CABG without cardiopulmonary bypass and cardioplegic arrest
Number of subjects: 114
Study: 11246304

Group type: EXPERIMENTAL
Intervention: Nasogastric sucralfate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intravenous ranitidine
Number of subjects: 20
Study: 9497019

Group type: EXPERIMENTAL
Intervention: 15 mg nicotine patch (Nicotrol)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: 80 mg oral cotinine fumarate
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Combination of nicotine patch and cotinine
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo drug
Number of subjects: 106
Study: 7979282

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 1 g administered immediately before PE (group I)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 3 g administered immediately before PE (group I)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 1 g administered 6 hours before PE (group II)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 3 g administered 6 hours before PE (group II)
Number of subjects: 12
Study: 2658529

Group type: EXPERIMENTAL
Intervention: Dilevalol administered once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dilevalol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 0
Study: 1174085

Group type: EXPERIMENTAL
Intervention: Bumetanide 0.25 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bumetanide 0.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bumetanide (general)
Number of subjects: 0
Study: 30506693

Group type: EXPERIMENTAL
Intervention: Adalimumab with immunomodulators
Number of subjects: 192

Group type: COMPARATOR
Intervention: Adalimumab monotherapy
Number of subjects: 192
Study: 27615542

Group type: EXPERIMENTAL
Intervention: Nutrition counseling intervention (monthly one-on-one sessions for 12 months)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard care and nutrition education materials (control group)
Number of subjects: 22
Study: 24810891

Group type: EXPERIMENTAL
Intervention: Endoluminal venous laser therapy (980 nm, continuous mode, 30 W)
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: High ligation and invaginating stripping
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: Combination of both (laser and high ligation)
Number of subjects: 449

Group type: COMPARATOR
Intervention: Control/Stripping (C/S)
Number of subjects: 449
Study: 23890679

Group type: EXPERIMENTAL
Intervention: Caseload midwifery
Number of subjects: 1532

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1532

Group type: EXPERIMENTAL
Intervention: Early admission to hospital (before cervix was 5 cm dilated)
Number of subjects: 1532

Group type: EXPERIMENTAL
Intervention: Augmentation of labour
Number of subjects: 1532

Group type: EXPERIMENTAL
Intervention: Use of epidural analgesia
Number of subjects: 1532
Study: 21568186

Group type: EXPERIMENTAL
Intervention: Complete prevention program
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Partial program
Number of subjects: 263

Group type: COMPARATOR
Intervention: Non-treatment control
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Participants who completed inter-session interactive activities
Number of subjects: 263
Study: 19450644

Group type: EXPERIMENTAL
Intervention: HIV-1 DNA prime-MVA boost vaccine
Number of subjects: 0
Study: 16676650

Group type: COMPARATOR
Intervention: Passive rewarming (PASS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Cranial-neck rewarming (CN)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Cranial-neck and inhalation rewarming (CNIR)
Number of subjects: 16
Study: 15537171

Group type: EXPERIMENTAL
Intervention: Investigational anti-malarial phytomedicine (AM1) 250mg capsule with 1000mg paracetamol (PCM) tablets
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1000mg paracetamol (PCM) tablets alone (control)
Number of subjects: 0
Study: 11501511

Group type: EXPERIMENTAL
Intervention: Calcitriol 3 microg g(‐1) ointment (Silkis ointment)
Number of subjects: 0
Study: 9217191

Group type: EXPERIMENTAL
Intervention: PEG-rHuMGDF at 0.03, 0.1, 0.3, or 1.0 microg/kg/d for 10 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PEG-rHuMGDF at 0.1 microg/kg/d
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8483855

Group type: EXPERIMENTAL
Intervention: Single session of family-oriented nutritional education
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Four multiple 90-min sessions of family-oriented nutritional education
Number of subjects: 295
Study: 3038418

Group type: EXPERIMENTAL
Intervention: Indomethacin (50 mg bid)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 9
Study: 29635502

Group type: EXPERIMENTAL
Intervention: Breastfeeding-promotion intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no breastfeeding-promotion intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Breastfeeding ≥12 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Breastfeeding <12 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Instrumental variable analysis for breastfeeding duration
Number of subjects: 0
Study: 26742700

Group type: EXPERIMENTAL
Intervention: Benidipine
Number of subjects: 88

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 88
Study: 24685559

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy and motivational enhancement therapy with additional check-ups
Number of subjects: 74

Group type: COMPARATOR
Intervention: Cognitive behavioral therapy and motivational enhancement therapy without additional check-ups
Number of subjects: 74
Study: 23797469

Group type: EXPERIMENTAL
Intervention: 0.625 mg CEE with or without 2.5 mg medroxyprogesterone acetate
Number of subjects: 1326

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1326
Study: 20588105

Group type: EXPERIMENTAL
Intervention: Low-dose ritonavir (100 mg daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Raltegravir (400 mg twice daily)
Number of subjects: 20
Study: 18763235

Group type: COMPARATOR
Intervention: Prolonged-release melatonin (PR-M) 2 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Zolpidem 10 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Combination of PR-M 2 mg and Zolpidem 10 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: COMPARATOR
Intervention: Next morning performance
Number of subjects: 16
Study: 16809807

Group type: EXPERIMENTAL
Intervention: 40 mg atorvastatin daily for 2 months
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 80 mg simvastatin daily for 2 months
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 44